[
  {
    "ts": null,
    "headline": "RMD Q1 Earnings Call: Margin Expansion and Demand Generation Initiatives Define Quarter",
    "summary": "Medical device company ResMed (NYSE:RMD) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 7.9% year on year to $1.29 billion. Its non-GAAP profit of $2.37 per share was in line with analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=cdc7aa9003bc20f3525021c621fbc80930df0d939de63575e673a19ca776ac60",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745705341,
      "headline": "RMD Q1 Earnings Call: Margin Expansion and Demand Generation Initiatives Define Quarter",
      "id": 134104799,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Medical device company ResMed (NYSE:RMD) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 7.9% year on year to $1.29 billion. Its non-GAAP profit of $2.37 per share was in line with analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=cdc7aa9003bc20f3525021c621fbc80930df0d939de63575e673a19ca776ac60"
    }
  }
]